Literature DB >> 11078559

Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

A E Lin1, P H Birch, B R Korf, R Tenconi, M Niimura, M Poyhonen, K Armfield Uhas, M Sigorini, R Virdis, C Romano, E Bonioli, P Wolkenstein, E K Pivnick, M Lawrence, J M Friedman.   

Abstract

Although it is well recognized that a peripheral vasculopathy may occur in patients with neurofibromatosis 1 (NF1), it is unclear whether cardiovascular abnormalities are more common. We reviewed the frequency of cardiovascular abnormalities, in particular, cardiovascular malformations (CVMs), among 2322 patients with definite NF1 in the National Neurofibromatosis Foundation International Database from 1991-98. Cardiovascular malformations were reported in 54/2322 (2.3%) of the NF1 patients, only 4 of whom had Watson syndrome or NF1-Noonan syndrome. There was a predominance of Class II "flow" defects [Clark, 1995: Moss and Adams' Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. p 60-70] (43/54, 80%) among the NF1 patients with CVMs. Pulmonic stenosis, that was present in 25 NF1 patients, and aortic coarctation, that occurred in 5, constitute much larger proportions of all CVMs than expected. Of interest was the paucity of Class I conotruncal defects (2 patients with tetralogy of Fallot), and the absence of atrioventricular canal, anomalous pulmonary venous return, complex single ventricle and laterality defects. Besides the 54 patients with CVMs, there were 27 patients with other cardiac abnormalities (16 with murmur, 5 with mitral valve prolapse, 1 with intracardiac tumor, and 5 with electrocardiogram abnormalities). No patient in this study had hypertrophic cardiomyopathy. There were 16 patients who had a peripheral vascular abnormality without an intracardiac CVM, plus an additional 4 patients among those with a CVM who also had a peripheral vascular abnormality. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11078559     DOI: 10.1002/1096-8628(20001113)95:2<108::aid-ajmg4>3.0.co;2-0

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  61 in total

1.  Nf1 has an essential role in endothelial cells.

Authors:  Aaron D Gitler; Yuan Zhu; Fraz A Ismat; Min Min Lu; Yasutaka Yamauchi; Luis F Parada; Jonathan A Epstein
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

Review 2.  Heart valve development: endothelial cell signaling and differentiation.

Authors:  Ehrin J Armstrong; Joyce Bischoff
Journal:  Circ Res       Date:  2004-09-03       Impact factor: 17.367

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

4.  Nf1 limits epicardial derivative expansion by regulating epithelial to mesenchymal transition and proliferation.

Authors:  Seung Tae Baek; Michelle D Tallquist
Journal:  Development       Date:  2012-04-25       Impact factor: 6.868

Review 5.  Endothelial-cardiomyocyte interactions in cardiac development and repair.

Authors:  Patrick C H Hsieh; Michael E Davis; Laura K Lisowski; Richard T Lee
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

Review 6.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

7.  Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice.

Authors:  Ki Beom Bae; Myoung Ok Kim; Dong Hoon Yu; Mi Jung Shin; Hei Jung Kim; Hyung Soo Yuh; Young Rae Ji; Jae-Young Kim; Jin Man Kim; Byung Hwa Hyun; Hwi Cheul Lee; Won Kyong Chang; Soo Bong Park; Do Hyung Kim; Hyun-Shik Lee; Yeon-Sik Choo; Sanggyu Lee; Zae Young Ryoo
Journal:  Transgenic Res       Date:  2011-01-09       Impact factor: 2.788

8.  Duplication and Deletion of 22q11 Associated with Anomalous Pulmonary Venous Connection.

Authors:  Ruixue Cao; Sijie Liu; Chunjie Liu; Sun Chen; Fen Li; Kun Sun; Rang Xu
Journal:  Pediatr Cardiol       Date:  2017-12-26       Impact factor: 1.655

9.  Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.

Authors:  Puhui Zhou; Tielin Chen; Yin Fang; Honglian Wang; Mi Li; Pengpeng Ma; Lu He; Qianyin Li; Tianming Liu; Xianggui Yang; Fang Nie; Xiaoyan Wang; Yue Yuan; Li Zhou; Rui Peng; Zhicheng Liu; Qin Zhou
Journal:  Mol Cell Biochem       Date:  2014-02-27       Impact factor: 3.396

10.  Neurofibromatosis type 1 and multiple traumatic cervical arterial injuries: a case report.

Authors:  Bertrand Sauneuf; Stéphanie Chevalier; Claude Jehan; Patrick Courtheoux; Jean-Louis Gérard; Jean-Luc Hanouz; Benoit Plaud
Journal:  Cases J       Date:  2009-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.